Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

CRBU

CRBU News

Newswire

16:07

Caribou Biosciences to Host KOL Event at ASH 2025 on Broadening Access to Second-Line Large B Cell Lymphoma Treatment with Vispa-cel

06:47

Caribou Biosciences: HC Wainwright Raises Buy Rating to $9 from $3.

18:49

Assessing Caribou Biosciences' Valuation After Early CB-011 CAR-T Data and Pipeline Progress

04:01

Caribou Biosciences shares surge 40.50% premarket on positive Phase 1 trial data for vispa-cel and CB-011, showing high efficacy in lymphoma and myeloma.

12:03

Caribou Biosciences Reports Positive CRISPR Genome-Editing Results, Stock Surges 17.56% on Monday

View More

About CRBU

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More